CINGOLANI, LINDA

CINGOLANI, LINDA  

Mostra records
Risultati 1 - 5 di 5 (tempo di esecuzione: 0.011 secondi).
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
Perception of the COVID-19 pandemic among patients with inflammatory bowel disease in the time of telemedicine: cross-sectional questionnaire study 2020 Zingone F.Savarino E. V.Barberio B.Cingolani L. + JMIR. JOURNAL OF MEDICAL INTERNET RESEARCH - -
A survey on nutritional knowledge in coeliac disease compared to inflammatory bowel diseases patients and healthy subjects 2020 Marsilio I.Savarino E. V.Barberio B.Lorenzon G.Maniero D.Cingolani L.Zingone F. + NUTRIENTS - -
Adalimumab biosimilars, ABP501 and SB5, are equally effective and safe as adalimumab originator 2021 Cingolani L.Barberio B.Zingone F.Melatti P.Gubbiotti A.Massimi D.Savarino E. V. + SCIENTIFIC REPORTS - -
Switching from Infliximab Originator to SB2 Biosimilar in Inflammatory Bowel Diseases: A Multicentric Prospective Real-Life Study 2021 Massimi D.Barberio B.Cingolani L.Zingone F.Savarino E. V. + THERAPEUTIC ADVANCES IN GASTROENTEROLOGY - -
A propensity score-weighted comparison between adalimumab originator and its biosimilars, ABP501 and SB5, in inflammatory bowel disease: a multicenter Italian study 2021 Barberio B.Cingolani L.Canova C.Buda A.Massimi D.Savarino E. V.Zingone F. + THERAPEUTIC ADVANCES IN GASTROENTEROLOGY - -